Cite
HARVARD Citation
Steenholdt, C. et al. (2014). Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial. Gut. 63 (6), pp. 919-927. [Online].